ADVANCED SOLID CANCERS
Clinical trials for ADVANCED SOLID CANCERS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID CANCERS trials appear
Sign up with your email to follow new studies for ADVANCED SOLID CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody drug targets advanced cancers in Mid-Stage trial
Disease control Recruiting nowThis study tests a new drug, PRL3-zumab, in 52 adults with advanced solid tumors that have not responded well to prior treatments. The drug is given every two weeks by IV. The main goal is to see how long the cancer stays under control and whether the drug is safe. This is not a …
Matched conditions: ADVANCED SOLID CANCERS
Phase: PHASE2, PHASE3 • Sponsor: Intra-IMMUSG Pte Ltd • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New cancer drug ADCX-020 enters first human trials for advanced tumors
Disease control Recruiting nowThis early-phase study tests a new cancer drug, ADCX-020, in about 290 adults with advanced solid tumors that have stopped responding to standard treatments. The drug is an antibody-drug conjugate designed to target and kill cancer cells. The study first finds a safe dose, then t…
Matched conditions: ADVANCED SOLID CANCERS
Phase: PHASE1 • Sponsor: Adcytherix SAS • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New drug BNT329 targets Hard-to-Treat cancers in first human trial
Disease control Recruiting nowThis study tests a new drug called BNT329 in people with advanced solid tumors that have a specific marker (CA19-9). The main goals are to check safety and find the best dose. About 245 participants will take part. The drug is designed to attack cancer cells while limiting harm t…
Matched conditions: ADVANCED SOLID CANCERS
Phase: PHASE1, PHASE2 • Sponsor: BioNTech SE • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Immune cell duo takes on tough tumors in early trial
Disease control Recruiting nowThis early-phase study tests a combination of two immune cell therapies—targeted dendritic cells and CAR-T cells—in 10 adults with advanced solid cancers like stomach, colon, or pancreatic cancer. The goal is to see if the treatment is safe and can shrink tumors by helping the im…
Matched conditions: ADVANCED SOLID CANCERS
Phase: EARLY_PHASE1 • Sponsor: Hainan Cancer Hospital • Aim: Disease control
Last updated May 13, 2026 15:58 UTC